Tag Archives: Discovery

Cross-Pollination of Information From Litigation to IPR Can Lead to Trouble for Parties

thumbnail image of DNA strandBy Katherine L. Neville, Ph.D. on Posted in Biotechnology, Discovery, Inter Partes Review
In a recent order by the magistrate judge in Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC (NJD, Jan. 22, 2016), defendants Amneal Pharmaceuticals and Par Pharmaceuticals were reprimanded and threatened with sanctions and monetary fines for trying to use confidential information from the litigation to move for additional discovery in a related IPR proceedings.  The judge … Continue Reading

Pharma Patent Owner Attacks Bass IPR Petitions by Requesting Discovery of Real Parties-In-Interest

thumbnail image of DNA strandBy Marshall Gerstein on Posted in Biotechnology, Discovery, Real Party-in-Interest
A picture can be worth a thousand words. This one illustrates the complex web of actual and potential real parties-in-interest (RPIs) that a pharmaceutical patent owner is attempting to pierce for two IPR petitions recently filed by Coalition For Affordable Drugs II—one of several similarly-named creations of hedge-fund manager Kyle Bass and his Hayman Credes … Continue Reading

PTAB Grants Joinder of Proceedings Raising Identical Challenges, but Required Adoption of the Previously Entered Trial Schedule

By Julianne M. Hartzell on Posted in Discovery, Inter Partes Review, Joinder
On May 22, 2015, the Board granted Petitioners Motion for Joinder in Mercedes-Benz USA, LLC and Mercedes-Benz U.S. International, Inc. v. Innovative Display Technologies, LLC, IPR2015-00360. Mercedes-Benz sought to join its proceeding with LG Display Co., Ltd. v. Innovative Display Technologies, LLC, IPR2015-00360, which was instituted on January 13, 2015. Mercedes-Benz filed its petition approximately … Continue Reading
LexBlog